Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spinal Muscular Atrophy Type 3”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Study completedNCT03781479
What this trial is testing

Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients

Who this might be right for
Muscular Atrophy, Spinal
Catalyst Pharmaceuticals, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT00227266
What this trial is testing

Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
University of Utah 94
Not applicableStudy completedNCT04576494
What this trial is testing

Study of the Functional Effects of Nusinersen in 5q-spinal Muscular Amyotrophy Adults (SMA Type 2 or 3 Forms)

Who this might be right for
Spinal Muscular Atrophy
CHU de Reims 4
Large-scale testing (Phase 3)Active Not RecruitingNCT05626855
What this trial is testing

Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab

Who this might be right for
Spinal Muscular AtrophySpinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 2+7 more
Scholar Rock, Inc. 238
Not applicableStudy completedNCT02003937
What this trial is testing

Aerobic Training in Patients With Spinal Muscular Atrophy Type III

Who this might be right for
Spinal Muscular Atrophy
Rigshospitalet, Denmark 15
Testing effectiveness (Phase 2)Study completedNCT05794139
What this trial is testing

Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
NMD Pharma A/S 52
Large-scale testing (Phase 3)Study completedNCT00774423
What this trial is testing

Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)

Who this might be right for
SMA
Assistance Publique - Hôpitaux de Paris 141
Not applicableUnknownNCT04888702
What this trial is testing

Holter of Movement in Patients with SMA Undergoing Treatment.

Who this might be right for
Spinal Muscular Atrophy
Centre Hospitalier Universitaire de Liege 30
Not applicableStudy completedNCT04404764
What this trial is testing

Characterization of the Clinical-epidemiological Profile of Patients With SMA5q Types II and III: Observational Study

Who this might be right for
Spinal Muscular Atrophy
Hospital Israelita Albert Einstein 155
Not applicableUnknownNCT05839145
What this trial is testing

Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study

Who this might be right for
Muscular Atrophy, Spinal, Type IIMuscular Atrophy, Spinal, Type III
Institut de Myologie, France 60
Large-scale testing (Phase 3)Study completedNCT03306277
What this trial is testing

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

Who this might be right for
SMA - Spinal Muscular AtrophyGene Therapy
Novartis Gene Therapies 22
Not applicableStudy completedNCT03878030
What this trial is testing

Effect of Nusinersen on Adults With Spinal Muscular Atrophy

Who this might be right for
Adult Spinal Muscular Atrophy
Northwell Health 12
Not applicableLooking for participantsNCT06562283
What this trial is testing

Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy

Who this might be right for
Spinal AmyotrophyInfantile Spinal Muscular AtrophyJuvenile Spinal Muscular Atrophy
Centre Hospitalier Universitaire de Saint Etienne 80
Not applicableUnknownNCT02831296
What this trial is testing

Prospective Evaluation of Infants With Spinal Muscular Atrophy:

Who this might be right for
Spinal Muscular Atrophy
Massachusetts General Hospital 1,000
Not applicableStudy completedNCT00466349
What this trial is testing

International SMA Patient Registry

Who this might be right for
Muscular Atrophy, Spinal
Indiana University 3,000
Testing effectiveness (Phase 2)Study completedNCT02908685
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 231
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Testing effectiveness (Phase 2)Study completedNCT00568802
What this trial is testing

A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients

Who this might be right for
Muscular Atrophy, Spinal
Stanford University 27
Testing effectiveness (Phase 2)Looking for participantsNCT06421831
What this trial is testing

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients

Who this might be right for
Spinal Muscular Atrophy Type 3
GeneCradle Inc 21
Testing effectiveness (Phase 2)Study completedNCT01302600
What this trial is testing

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

Who this might be right for
Spinal Muscular Atrophy Type IISpinal Muscular Atrophy Type III Non Ambulant
Hoffmann-La Roche 165
Next Page